Skip Nav Destination
CCR Focus Archive
CCR Focus, published quarterly, provides new and robust insights on a specific topic by experts in a way that is not only suited for those well versed in the area but also for other researchers interested in the field. Articles concentrate on analysis of available information, diagnosis of limitations in methodology, and identification of new trajectories that may lead to further discovery, inquiry, or interpretation.
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006
Clinical Trial Design Considerations in the
Immuno-oncology Era (September 1, 2017)
Breast Cancer Research: From Base Pairs to Populations (June 1, 2017)
Pancreatic Cancer: Challenge and Inspiration (April 1, 2017)
Breast Cancer Research: From Base Pairs to Populations (June 1, 2017)
Pancreatic Cancer: Challenge and Inspiration (April 1, 2017)
Multiple Myeloma: Multiplying Therapies (November 15, 2016)
Endocrine Cancers: Revising Paradigms (October 15, 2016)
New Approaches for Optimizing Dosing of Anticancer Agents (June 1, 2016)
Opportunities and Challenges in Cancer Immunotherapy (April 15, 2016)
Endocrine Cancers: Revising Paradigms (October 15, 2016)
New Approaches for Optimizing Dosing of Anticancer Agents (June 1, 2016)
Opportunities and Challenges in Cancer Immunotherapy (April 15, 2016)
Cell Death and Cancer Therapy (November 15, 2015)
Innovations to Speed Drug Development (October 15, 2015)
Progress in Lung Cancer (May 15, 2015)
Targeting RAS-Driven Cancers (April 15, 2015)
Innovations to Speed Drug Development (October 15, 2015)
Progress in Lung Cancer (May 15, 2015)
Targeting RAS-Driven Cancers (April 15, 2015)
Discoveries, Challenges, and Progress in Primary Brain Tumors (November 15, 2014)
Paradigm Shifts in Lymphoma (October 15, 2014)
Progress in Pharmacodynamic Endpoints (May 15, 2014)
The Precision Medicine Conundrum: Approaches to Companion Diagnostic Co-development (March 15, 2014)
Paradigm Shifts in Lymphoma (October 15, 2014)
Progress in Pharmacodynamic Endpoints (May 15, 2014)
The Precision Medicine Conundrum: Approaches to Companion Diagnostic Co-development (March 15, 2014)
Research in Breast Cancer: Frontiers in Genomics, Biology, and Clinical Investigation (December 1, 2013)
Novel Agents in Melanoma: A Pipeline for the Future (October 1, 2013)
Progression-Free Survival: Clinical and Statistical Challenges (May 15, 2013)
The Immune System as an Anticancer Agent (March 1, 2013)
Novel Agents in Melanoma: A Pipeline for the Future (October 1, 2013)
Progression-Free Survival: Clinical and Statistical Challenges (May 15, 2013)
The Immune System as an Anticancer Agent (March 1, 2013)
Oncogenic Metabolism: Cause or Consequence? (October 15, 2012)
Pancreatic Cancer—Applied Science—The Assault Begins (August 15, 2012)
Genetically InFormed Therapies for Children with Cancer (May 15, 2012)
Scientific and Regulatory Challenges in the Development of Molecular Diagnostics (March 15, 2012)
Clinical and Translational Cancer Research Think Tank Meeting (February 1, 2012)
Drug Development: What Experience Has Taught Us (January 1, 2012)
Pancreatic Cancer—Applied Science—The Assault Begins (August 15, 2012)
Genetically InFormed Therapies for Children with Cancer (May 15, 2012)
Scientific and Regulatory Challenges in the Development of Molecular Diagnostics (March 15, 2012)
Clinical and Translational Cancer Research Think Tank Meeting (February 1, 2012)
Drug Development: What Experience Has Taught Us (January 1, 2012)
Antibody Conjugates: Arming Antibodies to Create Better Anticancer Therapies (October 15, 2011)
A Triple for Prostate Cancer (June 15, 2011)
Progress and Paradigms in Myeloma (March 15, 011)
A Triple for Prostate Cancer (June 15, 2011)
Progress and Paradigms in Myeloma (March 15, 011)
Outcomes of New Cancer Therapies: Enhancing the Process and Creating Meaningful Value (December 15, 2010)
Re-energizing DNA Damage and Repair as a Therapeutic Target (September 15, 2010)
Targeting the Journey: From Embryogenesis to Cancer Stem Cell (June 15, 2010)
Phase I Trials: Critical Steps on the Critical Path (March 15, 2010)
Re-energizing DNA Damage and Repair as a Therapeutic Target (September 15, 2010)
Targeting the Journey: From Embryogenesis to Cancer Stem Cell (June 15, 2010)
Phase I Trials: Critical Steps on the Critical Path (March 15, 2010)
Resistance to Targeted Therapies: Back to the Future (December 15, 2009)
Lung Cancer in Never Smokers (September 15, 2009)
Epigenetic Therapies Reach Main Street (June 15, 2009)
Phase II Trials: Designs for the Future (March 15, 2009)
Lung Cancer in Never Smokers (September 15, 2009)
Epigenetic Therapies Reach Main Street (June 15, 2009)
Phase II Trials: Designs for the Future (March 15, 2009)
Breast Cancer: Pathways to Personalized Medicine (December 15, 2008)
Unraveling an Enigma: Biostatistics and Biomarkers (October 1, 2008)
Navigating Early Translational Cancer Research (September 15, 2008)
Phase 0 Trials (June 15, 2008)
New Cytotoxics in Oncology (March 15, 2008)
Unraveling an Enigma: Biostatistics and Biomarkers (October 1, 2008)
Navigating Early Translational Cancer Research (September 15, 2008)
Phase 0 Trials (June 15, 2008)
New Cytotoxics in Oncology (March 15, 2008)
Cell Death (December 15, 2007)
Immune Regulation and Immunotherapy (September 15, 2007)
Imaging Update: New Windows, New Views (June 15, 2007)
CNS Metastasis: An Old Problem in a New Guise (March 15, 2007)
Immune Regulation and Immunotherapy (September 15, 2007)
Imaging Update: New Windows, New Views (June 15, 2007)
CNS Metastasis: An Old Problem in a New Guise (March 15, 2007)
EGF Receptor: Mutations, Misregulation and More (December 15, 2006)
Mouse Models Get Another Chance (September 15, 2006)
Mouse Models Get Another Chance (September 15, 2006)
We welcome suggestions for future topics on our Feedback page.
RSS Feeds